Statistics for A prospective, randomised, double blind, placebo-controled, multi-centre trial to assess safety, efficacy, tolerability and immunogencity of influenza virus vaccine, trivalent types A & B, live cold-adapted, liquied formulation (CAIV-T), administered concomitantly with a combination live, attenuated, mumps, measles, and rubella vaccine in healthy children aged 11-24 months
Total visits
| views | |
|---|---|
| A prospective, randomised, double blind, placebo-controled, multi-centre trial to assess safety, efficacy, tolerability and immunogencity of influenza virus vaccine, trivalent types A & B, live cold-adapted, liquied formulation (CAIV-T), administered concomitantly with a combination live, attenuated, mumps, measles, and rubella vaccine in healthy children aged 11-24 months | 0 |
Total visits per month
| views | |
|---|---|
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |